Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1983 Sep;51:91–96. doi: 10.1289/ehp.835191

Cell-mediated cytotoxicity expressed by lymphoid cells from rats with asbestos-induced peritoneal mesothelioma towards rat fetal cell.

R H Stevens, D A Cole, H F Cheng, J A Hodge, L A Will
PMCID: PMC1569267  PMID: 6641663

Abstract

Cell-mediated immunity (CMI) directed towards rat fetal cells was evaluated in Fischer F344 young inbred male rats having asbestos-induced peritoneal mesothelioma. The tumors were induced by exposure to Canadian chrysotile B fibers and the CMI delineated by the injury and destruction brought about to 6- to 10-day-old primary fetal cell cultures by the so-called educated peripheral blood lymphoid-cells (PBLC) obtained from the cancer-bearing rats. A significant cytotoxicity was found to be expressed by the PBLCs, suggesting that during the development of mesothelioma, a cellular retrodifferentiation occurs, thereby educating the effectors to recognize a common determinant existing in both the tumor and fetal cells. Educated PBLCs were produced from rats having endodermal tissue cancers (adenocarcinomas of the small bowel, colon and pancreas) and were found to also be cytotoxic to the fetal cultures, yet no injury was apparently inflicted upon cultured mesothelioma target cells by these effectors. These results suggested that the tumor education was specific and that probably a unique and different fetal component was being recognized by the effector cells obtained from the rats with lesions arising either in the mesodermal or endodermal tissue. Further support for this concept was the failure of an antibody, specific to an oncofetal protein existing in endodermal lesions, to apparently recognize any common oncogenic proteins in the mesothelioma. Preliminary studies have also been accomplished which suggests the existence of natural killing immune responses existing to the mesothelioma target cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P. Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells? Cancer Res. 1974 Aug;34(8):2077–2082. [PubMed] [Google Scholar]
  2. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 1974;4(4):269–274. [PubMed] [Google Scholar]
  3. Brown D. G., Wagner J. C., Wagner M. M. Failure to demonstrate tumour-associated transplantation antigens on asbestos-induced mesotheliomas in rats. Br J Cancer. 1980 Nov;42(5):797–801. doi: 10.1038/bjc.1980.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown J. P., van Belle G., Hellström I. Design of experiments using the microcytotoxicity assay. Int J Cancer. 1976 Aug 15;18(2):230–235. doi: 10.1002/ijc.2910180213. [DOI] [PubMed] [Google Scholar]
  5. Cole D. A., Stevens R. H., Will L. A. Identification of carcinogens by measurement of cell-mediated immunity. III. Immunity to asbestos-induced rat peritoneal mesothelioma. Environ Res. 1982 Jun;28(1):77–83. doi: 10.1016/0013-9351(82)90155-4. [DOI] [PubMed] [Google Scholar]
  6. Coop K. L., Sharp J. G., Osborne J. W., Zimmerman G. R. An animal model for the study of small-bowel tumors. Cancer Res. 1974 Jun;34(6):1487–1494. [PubMed] [Google Scholar]
  7. Embleton M. J., Wagner J. C., Wagner M. M., Jones J. S., Sheers G., Oldham P. D., Baldwin R. W. Assessment of cell-mediated immunity to malignant mesothelioma by microcytotoxicity tests. Int J Cancer. 1976 May 15;17(5):597–601. doi: 10.1002/ijc.2910170507. [DOI] [PubMed] [Google Scholar]
  8. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Go V. L. Carcinoembryonic antigen: clinical application. Cancer. 1976 Jan;37(1 Suppl):562–566. doi: 10.1002/1097-0142(197601)37:1+<562::aid-cncr2820370721>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  10. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  12. Herberman R. B., Holden H. T. Natural killer cells as antitumor effector cells. J Natl Cancer Inst. 1979 Mar;62(3):441–445. doi: 10.1093/jnci/62.3.441. [DOI] [PubMed] [Google Scholar]
  13. Reddy B. S., Narisawa T., Wright P., Vukusich D., Weisburger J. H., Wynder E. L. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 1975 Feb;35(2):287–290. [PubMed] [Google Scholar]
  14. Stevens R. H., Brooks G. P., Osborne J. W., Englund C. W., White D. W. Lymphocyte cytotoxicity in X-irradiation-induced adenocarcinoma of the rat small bowel. I. Measurement of target cell destruction by release of radioiodinated membrane proteins: brief communication. J Natl Cancer Inst. 1977 Oct;59(4):1315–1319. doi: 10.1093/jnci/59.4.1315. [DOI] [PubMed] [Google Scholar]
  15. Stevens R. H., Cole D. A., Cheng H. F. Chemical-and X-ray-induced antitumor cell-mediated immunity to rat fetal cells. Oncodev Biol Med. 1982;3(2-3):201–208. [PubMed] [Google Scholar]
  16. Stevens R. H., Cole D. A., Cheng H. F. Identification of a common oncofoetal protein in x-ray and chemically induced rat gastrointestinal tumours. Br J Cancer. 1981 Jun;43(6):817–825. doi: 10.1038/bjc.1981.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stevens R. H., England C. W., Osborne J. W., Cheng H. F., Richerson H. B. Oncofetal protein accompanying irradiation-induced small-bowel adenocarcinoma in the rat. J Natl Cancer Inst. 1975 Oct;55(4):1011–1013. doi: 10.1093/jnci/55.4.1011. [DOI] [PubMed] [Google Scholar]
  18. Stevens R. H., Englund C. W., Osborne J. W., Cheng H. F., Hoffman K. L. Identification and characterization of a circulating tumor-associated oncofetal protein from a radiation-induced adenocarcinoma of the rat small bowel. Cancer Res. 1976 Sep;36(9 PT1):3260–3264. [PubMed] [Google Scholar]
  19. Stevens R. H., Graves J. M., Meek E. S., Osborne J. W., Cheng H. F., Loven D. P. Cyclic nucleotide concentrations in 7.12-dimethylbenz[a]anthracene-induced pancreatic cancer in rats. J Natl Cancer Inst. 1978 Nov;61(5):1281–1284. doi: 10.1093/jnci/61.5.1281. [DOI] [PubMed] [Google Scholar]
  20. Uriel J. Cancer, retrodifferentiation, and the myth of Faust. Cancer Res. 1976 Nov;36(11 Pt 2):4269–4275. [PubMed] [Google Scholar]
  21. Uriel J. Transitory liver antigens and primary hepatoma in man and rat. Pathol Biol (Paris) 1969 Oct;17(19):877–884. [PubMed] [Google Scholar]
  22. Wang N. S., Huang S. N., Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. doi: 10.1002/1097-0142(197909)44:3<937::aid-cncr2820440322>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES